FAZIOLI, Francesca
 Distribuzione geografica
Continente #
NA - Nord America 5.302
EU - Europa 3.231
AS - Asia 1.836
SA - Sud America 367
AF - Africa 137
Continente sconosciuto - Info sul continente non disponibili 86
OC - Oceania 12
Totale 10.971
Nazione #
US - Stati Uniti d'America 5.188
RU - Federazione Russa 1.577
SG - Singapore 556
VN - Vietnam 435
IT - Italia 386
BR - Brasile 298
CN - Cina 290
UA - Ucraina 271
HK - Hong Kong 204
SE - Svezia 196
DE - Germania 178
IE - Irlanda 152
FR - Francia 108
DK - Danimarca 103
TR - Turchia 94
CI - Costa d'Avorio 89
GB - Regno Unito 81
FI - Finlandia 80
CA - Canada 76
KR - Corea 57
BD - Bangladesh 41
IN - India 33
AR - Argentina 29
NL - Olanda 28
MX - Messico 26
JP - Giappone 21
BE - Belgio 19
ZA - Sudafrica 15
IQ - Iraq 13
CO - Colombia 12
PL - Polonia 12
ID - Indonesia 11
AT - Austria 10
PH - Filippine 10
SA - Arabia Saudita 10
CL - Cile 9
MA - Marocco 8
NZ - Nuova Zelanda 8
DZ - Algeria 7
EC - Ecuador 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
PK - Pakistan 6
UZ - Uzbekistan 6
ES - Italia 5
JO - Giordania 5
RS - Serbia 5
SY - Repubblica araba siriana 5
AU - Australia 4
CZ - Repubblica Ceca 4
ET - Etiopia 4
JM - Giamaica 4
OM - Oman 4
TH - Thailandia 4
AZ - Azerbaigian 3
CH - Svizzera 3
EG - Egitto 3
EU - Europa 3
IL - Israele 3
KE - Kenya 3
KZ - Kazakistan 3
MY - Malesia 3
PY - Paraguay 3
RO - Romania 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CR - Costa Rica 2
HR - Croazia 2
NG - Nigeria 2
NP - Nepal 2
PS - Palestinian Territory 2
TW - Taiwan 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
CG - Congo 1
CY - Cipro 1
EE - Estonia 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
KG - Kirghizistan 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
MC - Monaco 1
MD - Moldavia 1
NI - Nicaragua 1
PA - Panama 1
PE - Perù 1
SN - Senegal 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.891
Città #
Dallas 1.480
Ashburn 468
Chandler 352
Singapore 330
Des Moines 290
Jacksonville 270
Hong Kong 192
San Jose 162
Boardman 161
Fairfield 159
Ho Chi Minh City 155
Dublin 151
New York 129
Council Bluffs 128
Ann Arbor 120
Hanoi 94
Abidjan 89
Wilmington 89
Houston 87
Woodbridge 85
Beijing 77
The Dalles 69
Los Angeles 67
Seattle 61
Lawrence 59
Princeton 59
San Mateo 57
Lauterbourg 54
Cambridge 53
Milan 50
Moscow 49
Hefei 44
Centro 33
São Paulo 32
Marche 31
Ottawa 28
Munich 27
Turin 24
Buffalo 21
Da Nang 21
Helsinki 21
Redmond 20
Brussels 19
Haiphong 17
Orem 17
Rome 17
San Diego 17
Ancona 15
Tokyo 15
Chicago 14
Poplar 13
Santa Clara 13
London 12
Montreal 12
Guangzhou 11
Washington 11
Boston 10
Tampa 10
Warsaw 10
Chennai 9
Columbus 9
Denver 9
Mexico City 9
Nuremberg 9
Brasília 8
Dhaka 8
Manchester 8
Phoenix 8
Salt Lake City 8
Turku 8
Belo Horizonte 7
Brooklyn 7
Curitiba 7
Elk Grove Village 7
Frankfurt am Main 7
Hải Dương 7
Norwalk 7
Porto Alegre 7
Wuhan 7
Atlanta 6
Biên Hòa 6
Jakarta 6
Johannesburg 6
Miami 6
Naples 6
Padova 6
Ribeirão Preto 6
San Francisco 6
Shanghai 6
Tashkent 6
Trieste 6
Amman 5
Amsterdam 5
Bogotá 5
Can Tho 5
Quận Ba 5
Rio de Janeiro 5
Seoul 5
Tolentino 5
Vienna 5
Totale 6.454
Nome #
110 SERUM LEVELS OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR AND EPIDERMAL GROWTH FACTOR RECEPTOR IN PATIENTS WITH PROSTATE CANCER AND BENIGN PROSTATIC HYPERPLASIA 2.232
Circulating inflamma-miRs in aging and age-related diseases. 814
Circulating Inflamma-miRs as Potential Biomarkers of Cognitive Impairment in Patients Affected by Alzheimer's Disease 235
Cytotoxic and genotoxic potential of asbestos fibers from environmental outcrops 219
Analysis of M1 and M2 tumor associated macrophages in tongue squamous cell carcinomas. 213
Cytotoxicity in vitro of two non-commercial samples of chrysotile and fibrous erionite 210
Activation of transcription factors STAT1 and STAT5 in the mouse median eminence after systemic ciliary neurotrophic factor administration 204
Differences in survivin localization and Bcl-2 expression in CD30+ lymphoproliferative disorderd of the skin compared to systemic anaplastic large cell lymphomas: an immunohistochemical study 201
In Vitro H2O2 Stress And Patterns Of Mitochondrial Damage In The Nctc 2544 Continuous Cell Line 200
Fisiopatologia degli organi emopoietici e del sangue 186
A new germline point mutation in Ret exon 8 (cys515ser) in a family with medullary thyroid carcinoma 171
Prognostic Relevance of Macrophage Phenotypes in High-grade Oral Tongue Squamous Cell Carcinomas 168
Biosynthesis and apical localization of the urokinase receptor in polarized MDCK epithelial cells. 162
A ligand-inducible anaplastic lymphoma kinase chimera is endocytosis impaired 161
Asbestos induced toxicity: in vitro different effects of different fibres. 160
Activation of alpha-diacylglycerol kinase is critical for the mitogenic properties of anaplastic lymphoma kinase 151
Low FasL levels promote proliferation of human bone marrow-derived mesenchymal stem cells, higher levels inhibit their differentiation into adipocytes. 150
Identification and biochemical characterization of novel putative substrates for the epidermal growth factor receptor kinase. 149
Plasma levels of interleukin-38 in healthy aging and in type 2 diabetes 148
The Experimental Pathology at Ancona: 50 Years of Exciting and Pioneering Research on Human Pathology 147
Absence of somatic mutations in natriuretic peptide receptor type A gene in human aldosterone-secreting adenomas 146
Eps8, a substrate for the epidermal growth factor receptor kinase, enhances EGF-dependent mitogenic signals. 144
The carboxy-terminal domains of erbB-2 and epidermal growth factor receptor exert different regulatory effects on intrinsic receptor tyrosine kinase function and transforming activity. 141
A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity. 140
Integrin-dependent induction of functional urokinase receptors in primary T lymphocytes. 137
A paracrine circuit in the regulation of the proliferation of macrophages infiltrating murine sarcomas. 135
Constitutive expression of IL-1 beta, M-CSF and c-fms during the myeloid blastic phase of chronic myelogenous leukaemia. 133
The juxtamembrane regions of the epidermal growth factor receptor and gp185erbB-2 determine the specificity of signal transduction. 133
miR-132–3p is down-regulated in plasma and CD171+ extracellular vesicles isolated from patients with mild Alzheimer’s disease 131
Sex/gender-related differences in inflammaging 130
erbB-2 autophosphorylation is required for mitogenic action and high-affinity substrate coupling. 127
Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect. 126
Cancerogenesi chimica e fisica 126
77 Soluble urokinase receptor expression in urine is a prognostic marker in patients with transitional cell carcinoma of the bladder 124
eps15, a novel tyrosine kinase substrate, exhibits transforming activity. 122
Analisys of Y-linked microdeletions in idiopathic oligo- and azoospermic patients 122
Coenzyme Q10 levels in idiopathic and varicocele-associated asthenozoospermia 119
Removal of domain D2 or D3 of the human urokinase receptor does not affect ligand affinity. 118
Expression of Met protein and urokinase-type plasminogen activator receptor (uPA-R) in papillary carcinoma of the thyroid. 116
Prognostic value analysis of urokinase-type plasminogen activator receptor in oral squamous cell carcinoma: an immunohistochemical study. 116
A ligand-inducible epidermal growth factor receptor/anaplastic lymphoma kinase chimera promotes mitogenesis and transforming properties in 3T3 cells 116
Expression of growth hormone-releasing hormone receptor splicing variants in human primary adrenocortical tumours 111
Immunohistochemical evaluation of urokinase plasminogen activator receptor in noninvasive and early invasive urothelial papillary neoplasia. 111
Polynucleotide and substrate for the epidermal growth factor receptor kinase (EPS8) 107
Direct binding of eps8 to the juxtamembrane domain of EGFR is phosphotyrosine- and SH2-independent. 106
Evaluation of epidermal growth factor receptor and urokinase-type plasminogen activator receptor in serum of prostate cancer patients 106
DNA encoding human and murine EPS15, a substrate for the epidermal growth factor receptor 104
The Pro/Pro genotype of the p53 codon 72 polymorphism modulates PAI-1 plasma levels in ageing. 104
Bridging the gap between toxicity and carcinogenicity of mineral fibres by connecting the fibre parameters to the key characteristics of carcinogens: a comprehensive model inspiring asbestos-induced cancer prevention strategies 103
Increased urokinase-type plasminogen activator receptor and epidermal growth factor receptor in serum of patients with prostate cancer 100
uPAR mimicking peptides 95
In Vitro H202 stress and patterns of mitochondrial damage in the NCTC 2544 Continuous cell line- a morphological and morphometric study. 91
SERUM SOLUBLE UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR (SUPAR) IS A USEFUL MARKER OF PROSTATE CANCER 91
Evaluation of epidermal growth factor receptor and urokinase-type plasminogen activator receptor in serum of prostate cancer patients 90
Serum soluble urokinase-type plasminigen activator receptor (Supar) is a useful marker of prostate cancer 87
Survivin detection in saliva samples from patient with oral squamous cell carcinoma 84
Levels of urokinase-type plasminogen activator receptor inserum and urine of bladder cancer patients. Preliminaryresults 82
The erbB-2 mitogenic signaling pathway: tyrosine phosphorylation of phospholipase C-gamma and GTPase-activating protein does not correlate with erbB-2 mitogenic potency. 75
Purification of tyrosine phosphorylated proteins by immunoaffinity chromatography and direct cloning of their cDNAs from bacterial expression libraries 74
Src-dependence and pertussis-toxin sensitivity of urokinase receptor-dependent chemotaxis and cytoskeleton reorganization in rat smooth muscle cells 70
Urokinase-type plasminogen activator and its receptor: new targets for anti-metastatic therapy? 69
PPARγ expression in normal human placenta, hydatidiform mole and choriocarcinoma 67
The ezrin-like family of tyrosine kinase substrates: receptor-specific pattern of tyrosine phosphorylation and relationship to malignant transformation. 61
Totale 10.971
Categoria #
all - tutte 35.842
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.842


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022430 0 94 2 21 10 32 18 36 33 41 52 91
2022/20231.183 78 109 80 98 83 357 2 63 220 6 61 26
2023/2024590 89 15 35 99 93 123 9 14 2 28 15 68
2024/20251.148 163 87 68 8 47 24 121 59 227 120 103 121
2025/20265.605 248 562 1.128 319 272 233 624 264 1.525 203 119 108
2026/2027216 138 78 0 0 0 0 0 0 0 0 0 0
Totale 10.971